MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.
Crinière E, Kaloshi G, Laigle-Donadey F, Lejeune J, Auger N, Benouaich-Amiel A, Everhard S, Mokhtari K, Polivka M, Delattre JY, Hoang-Xuan K, Thillet J, Sanson M.
Crinière E, et al. Among authors: delattre jy.
J Neurooncol. 2007 Jun;83(2):173-9. doi: 10.1007/s11060-006-9320-0. Epub 2007 Jan 12.
J Neurooncol. 2007.
PMID: 17219056